Article
Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients.
International journal of clinical pharmacology research - 1 Jan 2005
Balanescu A, Radu E, Nat R, Regalia T, Bojinca V, Ionescu R, Balanescu S, Savu C, Predeteanu D
Abstract excerpt
The aim of this study was to analyze the phenotype of circulating dendritic cells (DCc) in rheumatoid arthritis (RA) patients before and after treatment with infliximab (at 24 h and 6 months) and the correlation between these changes and the clinical response to treatment. Sixteen patients with RA were recruited and clinical status was determined using the Disease Activity Score 28 (DAS28). All patients had...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
